ARV Management of Newborns with Perinatal HIV Exposure or HIV Infection
Antiretroviral Management of Newborns with Perinatal HIV Exposure or HIV Infection DHHS Last Updated: April 2023Australian Commentary Last Updated: July 2023 AU Comment: Australian national guidance Although some Australian states and territories have individual perinatal guidelines, Australian National guidance is primarily available via the ASID Management of Perinatal Infections guidelines, which are in turn based on […]
Special Considerations for ART Use in Adolescents with HIV
Special Considerations in Antiretroviral Therapy Use in Adolescents with HIV DHHS Last Updated: April 2023Australian Commentary Last Updated: July 2023 AU Comment: Adolescents living with HIV ASHM provides some guidance for clinicians in Australasia managing adolescents living with HIV and their transition to adult services, refer to HIV Management Guidelines, chapter: HIV infection in adolescents transitioning […]
Adherence to ART in Children and Adolescents with HIV
Adherence to Antiretroviral Therapy in Children and Adolescents with HIV DHHS Last Updated: April 2023Australian Commentary Last Updated: July 2023 Panel’s Recommendations Strategies to maximize adherence should be discussed before and/or at initiation of antiretroviral therapy (ART) and before changing regimens(AIII). Adherence to therapy must be assessed and promoted at each visit, and strategies to […]
Management of Medication Toxicity or Intolerance
Management of Medication Toxicity or Intolerance – Overview DHHS Last Updated: April 2023Australian Commentary Last Updated: July 2023 Panel’s Recommendations In children with HIV who have severe or life-threatening toxicity (e.g., a hypersensitivity reaction), all antiretroviral (ARV) drugs should be stopped immediately (AIII). Once symptoms of toxicity have resolved, ARV therapy should be resumed with substitution of […]
Management of Children Receiving ART
Management of Children Receiving Antiretroviral Therapy DHHS Last Updated: April 2023Australian Commentary Last Updated: July 2023 AU Comment: Raltegravir granules Raltegravir granules are NOT currently available in Australia. AU Comment: Age and weight based criteria Age and weight based criteria may differ in Australia. AU Comment: Maraviroc Maraviroc is NOT licensed for children in Australia. AU Comment: ibalizumab ibalizumab is NOT currently […]
ART Interruption in Children with HIV
Management of Children Receiving Antiretroviral Therapy DHHS Last Updated: April 2023 Panel’s Recommendations Outside the context of clinical trials, structured interruptions of antiretroviral therapy are not recommended for children (AII). Rating of Recommendations: A = Strong; B = Moderate; C = Optional Rating of Evidence: I = One or more randomized trials in children† with clinical outcomes and/or validated endpoints; I* […]
Committee
ASHM HIV Paediatric Guidelines Committee The Australian Commentary has been written and reviewed by members of the ASHM HIV Paediatric Guidelines Committee. The members of the Committee and other contributors who contributed to the Australian Commentary from 2020-2023 are listed below: Name Position Adam Bartlett (chair) Research Fellow, The Kirby Institute Paediatric Infectious Diseases Physician, Sydney […]